Kadmon is a biotech firm dedicated to creating lifesaving therapies for patients with unmet medical needs. The company is developing a range of innovative products, with a focus on inflammatory and fibrotic diseases and immuno-oncology. Led by an experienced management team, Kadmon is rapidly emerging as a leader in the biopharmaceutical world, as it continues to make significant strides toward commercializing its cutting-edge treatments. With an impressive pipeline of groundbreaking therapies in development, Kadmon is poised for success in the years to come.
Kadmon Holdings, Inc.'s ticker is KDMN
The company's shares trade on the NYSE stock exchange
They are based in New York City, New York
There are 51-200 employees working at Kadmon Holdings, Inc.
It is https://kadmon.com/
Kadmon Holdings, Inc. is in the Healthcare sector
Kadmon Holdings, Inc. is in the Biotechnology industry
The following five companies are Kadmon Holdings, Inc.'s industry peers: